Morgan Stanley Ingevity Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Ingevity Corp stock. As of the latest transaction made, Morgan Stanley holds 448,512 shares of NGVT stock, worth $20.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

448,512

Previous 396,246 13.19%

Holding current value

$20.6 Million

Previous $15.5 Million 18.27%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.62 - $50.21 $1.65 Million - $2.62 Million	52,266 Added 13.19%	448,512 $18.3 Million
Q3 2024 Nov 14, 2024	SELL	$32.91 - $47.24 $2.06 Million - $2.95 Million	-62,523 Reduced 13.63%	396,246 $15.5 Million
Q2 2024 Oct 17, 2024	SELL	$43.47 - $55.12 $1.13 Million - $1.43 Million	-26,007 Reduced 5.36%	458,769 $20.1 Million
Q2 2024 Aug 14, 2024	SELL	$43.47 - $55.12 $1.13 Million - $1.43 Million	-26,007 Reduced 5.36%	458,769 $20.1 Million
Q1 2024 Oct 17, 2024	BUY	$40.04 - $48.95 $1.04 Million - $1.27 Million	26,007 Added 5.67%	484,776 $23.1 Million
Q1 2024 Aug 16, 2024	SELL	$40.04 - $48.95 $385,385 - $471,143	-9,625 Reduced 1.95%	484,776 $23.1 Million
Q1 2024 May 15, 2024	SELL	$40.04 - $48.95 $385,385 - $471,143	-9,625 Reduced 1.95%	484,776 $23.1 Million
Q4 2023 Aug 16, 2024	BUY	$37.42 - $47.96 $1.33 Million - $1.71 Million	35,632 Added 7.77%	494,401 $23.3 Million
Q4 2023 Feb 13, 2024	BUY	$37.42 - $47.96 $4.58 Million - $5.87 Million	122,496 Added 32.94%	494,401 $23.3 Million
Q3 2023 Nov 15, 2023	BUY	$46.86 - $64.31 $372,208 - $510,814	7,943 Added 2.18%	371,905 $17.7 Million
Q2 2023 Aug 14, 2023	BUY	$47.19 - $74.01 $3.95 Million - $6.2 Million	83,760 Added 29.89%	363,962 $21.2 Million
Q1 2023 May 15, 2023	SELL	$68.71 - $90.75 $1.48 Million - $1.95 Million	-21,512 Reduced 7.13%	280,202 $20 Million
Q4 2022 Feb 14, 2023	BUY	$61.2 - $78.95 $1.53 Million - $1.98 Million	25,033 Added 9.05%	301,714 $21.3 Million
Q3 2022 Nov 14, 2022	SELL	$60.02 - $75.11 $3.43 Million - $4.29 Million	-57,099 Reduced 17.11%	276,681 $16.8 Million
Q2 2022 Oct 27, 2022	BUY	$59.46 - $74.1 $12.1 Million - $15.1 Million	203,535 Added 156.27%	333,780 $21.1 Million
Q2 2022 Aug 15, 2022	BUY	$59.46 - $74.1 $12.1 Million - $15.1 Million	203,535 Added 156.27%	333,780 $21.1 Million
Q1 2022 Oct 27, 2022	SELL	$56.58 - $75.67 $11.5 Million - $15.4 Million	-203,535 Reduced 60.98%	130,245 $8.34 Million
Q1 2022 May 13, 2022	SELL	$56.58 - $75.67 $4.42 Million - $5.92 Million	-78,195 Reduced 37.51%	130,245 $8.34 Million
Q4 2021 Feb 14, 2022	SELL	$69.65 - $83.18 $805,014 - $961,394	-11,558 Reduced 5.25%	208,440 $14.9 Million
Q3 2021 Nov 15, 2021	BUY	$69.6 - $87.31 $15.3 Million - $19.2 Million	219,998 New	219,998 $15.7 Million

Others Institutions Holding NGVT

# of Institutions

274

Shares Held

36.7M

Call Options Held

1.9K

Put Options Held

2.6K

View Full List

About Ingevity Corp

Ticker NGVT
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 38,048,800
Market Cap $1.75B
Description
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells har...

More about NGVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account